Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Web Exclusives
FDA Approvals
,
In the News
Government Shutdown Impacts FDA Drug Approvals
Read More
FDA Approvals
A “Gold Standard” for Population Health? Revisiting the FDA’s Relationship with the Hippocratic Oath
Read More
Press Releases
,
Original Research
Researchers Identify 4 Predictors of Transition to Chronic Opioid Use Based on Readily Available Opioid Regimen and Patient Factors
Read More
Press Releases
Access Market Intelligence Introduces Online Glossary of Common Drug Related Terms and Acronyms as e-Book
Read More
FDA Approvals
First FDA-Approved Test to Help Detect Several Leukemias and Lymphomas
Read More
FDA Approvals
First CAR T-Cell Therapy Unanimously Recommended by FDA Advisory Committee for Treatment of B-Cell ALL in Children and Young Adults
Read More
FDA Approvals
,
In the News
Rituximab Combination Now Approved in 3 Blood Cancers
Read More
FDA Approvals
Darzalex Combined with Pomalidomide and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma
Read More
FDA Approvals
Keytruda First Cancer Drug Approved for Any Solid Tumor Based on a Biomarker Instead of Tumor Site
Read More
FDA Approvals
Imfinzi a New PD-L1 Approved for Bladder Cancer After Platinum-Based Chemotherapy
Read More
18
19
20
21
22
23
24
Page 21 of 37
Results 201 - 210 of 362